APO

ACTUALITES

Weak Vaccine-Preventable Disease Surveillance Could Cost the African Region $22.4 billion over the next decade, World Health Organization (WHO) Warns

In its newly launched Investment Case for Vaccine-Preventable Disease Surveillance in the African Region, 2020-2030, the World Health Organization (WHO) Regional Office for Africa’s highlights the drastic consequences that could be in store for the region, if countries do not invest in disease surveillance efforts – including a US$22.